Blog - Page 5124 of 5517

TuesdayJul 10, 2007 6:33 am

Wall Street News Highlights Ultitek Ltd. (UITK.OB) as the Company Prepares to Enter the Airline Distribution Marketplace

Ultitek has been a provider of computerized Airline Reservation Systems software since 1989. The company has grown significantly since then and has serviced over 9 million passengers on 60 different airlines. The company announced earlier this week that it will not sublicense its Distribution System and will instead enter the Airline Distribution business directly. The CEO stated, “The Airline Distribution marketplace is too lucrative to pass up. The time is right for Ultitek to exploit our technical expertise and increase our revenues and profits.” On May 30th, the company announced that it increased revenues 29% for the first quarter. The…

TuesdayJul 10, 2007 6:09 am

VIASPACE, Inc. (VSPC.OB) Adds the University of Connecticut to Its Growing List of Customers

VIASPACE announced this morning that it has increased its sales base by expanding into the University market after the University of Connecticut ordered its humidity sensor. The University is engaged in fuel cell R&D which is funded by federal, state and local governments in addition to major corporations. The VIASENSOR HS-1000 humidity instrument provides real-time measurements of the amount of water vapor in gas streams. The sensor is extremely important as the performance of hydrogen fuel cells using a Polymer Electrolyte Membrane (PEM) depend on the moisture level. The CEO of VIASPACE, Carl Kukkonen stated, “We are delighted to add…

TuesdayJul 10, 2007 4:31 am

Reed’s, Inc. (REED.OB) Featured on Leading Financial Television Network

The CEO of Reed’s, Inc., Chris Reed, appeared on CNBC's "On The Money" show yesterday evening after a live interview with Mike Hegedus. The recorded show is expected to be displayed on Reed’s website soon. The first Reed’s Ginger Brew went into a bottle 23 years ago and is now the ‘coke’ of natural foods. The company’s natural, ginger and other herb ingredients drive the company to growing sales. The company’s core growth strategy is to broaden their brand recognition through additional points of distribution. Their recently announced exclusive distribution agreements will enable them to distribute to the mainstream marketplace and generate…

TuesdayJul 10, 2007 3:58 am

Cord Blood America, Inc. (CBAI.OB) Subsidiary’s Experienced Team and History Positions the Company to Reach Thousands of Families

Cord Blood America’s Subsidiary, CorCell, is a licensed and accredited cord blood company who has been dedicated to its work since 1995. Their stem-cell harvesting procedure is preferred by obstetricians for its safe, simple, and uncomplicated method. The company began in Pennsylvania as the first private cord blood company licensed for umbilical cord blood collection and is now a leader in the industry. The precious stem-cells are stored in its private laboratory which is both internationally known and AABB accredited. CorCell is focused on helping families protect future wellness, and will achieve its mission through educating and promoting the value…

MondayJul 09, 2007 6:49 pm

Fearless International (FRLE.OB) and Porsche Create Luxury Yacht

Shares of Fearless International (OTCBB: FRLE) climbed 2 cents, nearly 5 percent, to 45 cents this afternoon. The company is collaborating with Porsche Design Studio Austria to design custom yachts, combining marine and automotive characteristics to produce luxurious 28-150 feet water crafts.The first model, Fearless 28, hit the water February 28, 2007 - in the next three years, the company will unleash the 44, 68, 125 and 150 models. "To give you an idea of yachts and the way we're designing them with the Porsche design team, for a 125-foot yacht with a 26-foot beam, you'll be able to cruise…

MondayJul 09, 2007 6:49 pm

Top Closers with Big News

Every public company loves to put out good news and see the reflection in its stock price. The following three companies released positive news of some kind today or late yesterday and then watched as their stock prices closed very strong.Northwest Biotherapuetics Inc. (OTCBB: NWBO) announced today that they received authorization for use from the Swiss Institute of Public Health to make DCVax-Brain commercially available for treatment of brain cancer in Switzerland. Northwest intends to make the product available to patients in the 3rd quarter of 2007. The stock price for Northwest is up $5.23 to $7.33, which is up…

MondayJul 09, 2007 6:49 pm

AmeriFirst Lawyer Denouces SEC Allegations

If you've been following the recent activity in the Securities and Exchange Commission (SEC), then you know all about the SEC's recent scrutiny of Texas-based bank holdings company AmeriFirst. In a complaint filed Monday, July 2, the SEC leveled numerous accusations of investor fraud and financial mismanagement against the company, claiming that the company's investment opportunities "attracted investors with false promises of safety," and that company management used "much of their victim's money for their personal benefit." The SEC then filed an emergency action against the company to halt AmeriFirst's offering of securities - Secured Debt Obligations, or SDOs -…

MondayJul 09, 2007 6:49 pm

Global Resource Corporation (GBRC.OB) Announces Results from Energy Conversion Engine

Medical news always grabs attention in the stock community, especially when it involves cancer. That's why it's no surprise that share prices for Northwest Biotherapeautics Inc. (OTCBB: NWBO) skyrocketed a whopping 135 percent by midday after the company announced that it had developed the world's first commercially available brain cancer vaccine.According to a recent Northwest statement, the company's DCVax-Brain platform technology has been approved for commercial use in Switzerland, making it the first commercially available therapeutic vaccine for brain cancer victims. The statement claims that both newly diagnosed and recurrent brain cancer patients treated with DCVax-Brain had "more than double"…

MondayJul 09, 2007 6:49 pm

Northwest Biotherapeautics Inc (NWBO.OB) Shares Skyrocket with News of Cancer Vaccine

MondayJul 09, 2007 6:49 pm

CardioVascular BioTherapeutics Inc (CVBT.OB) Puts New Technology to the Test to Halt Heart Disease

Shares of CardioVascular BioTherapeutics Inc. (OTCBB: CVBT) rose 16.3 percent Friday to $1.07 due to highlights of its new angiogenesis treatment for those suffering from heart disease.Cardiovascular disease is no doubt a big issue for not only those inflicted with it, but also for a highly scrutinized healthcare system, due to the cost of necessary treatments. This disease strikes over 36 percent of the population in the U.S., resulting in 2,400 deaths each day. With this in mind, people in the medical industry have been waiting a long time for a better approach to angiogenesis treatment, which is the growth…

Site Search

Company Search

Wall Street News Highlights Ultitek Ltd. (UITK.OB) as the Company Prepares to Enter the Airline Distribution Marketplace

VIASPACE, Inc. (VSPC.OB) Adds the University of Connecticut to Its Growing List of Customers

Reed’s, Inc. (REED.OB) Featured on Leading Financial Television Network

Cord Blood America, Inc. (CBAI.OB) Subsidiary’s Experienced Team and History Positions the Company to Reach Thousands of Families

Fearless International (FRLE.OB) and Porsche Create Luxury Yacht

Top Closers with Big News

AmeriFirst Lawyer Denouces SEC Allegations

Global Resource Corporation (GBRC.OB) Announces Results from Energy Conversion Engine

Northwest Biotherapeautics Inc (NWBO.OB) Shares Skyrocket with News of Cancer Vaccine

CardioVascular BioTherapeutics Inc (CVBT.OB) Puts New Technology to the Test to Halt Heart Disease

Market Basics

Newsletter Publishers

Public Companies